Divya Venkat

Divya Venkat practices at Rush University Medical Center in Chicago, Illinois, part of Rush System for Health.

Divya Venkat's NPI, 1750944831, was assigned on April 15, 2019. Divya Venkat holds Illinois license 036161090.

Divya Venkat's primary practice is Rush University Medical Center, at 1653 West Congress Parkway, Chicago, IL 60612 in Cook County. The practice phone is (312) 942-5000.

Divya Venkat's primary practice is Rush University Medical Center in Chicago, Illinois, part of Rush System for Health. The medical group on file is Rush University Internists. Dmand AI also links Divya Venkat to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Divya Venkat practices, 2 sites in all. Vendor and product names are available with a free account.

Internal medicine is Divya Venkat's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Divya Venkat is licensed in Illinois.

CMS data shows 47 Medicare services from Divya Venkat across 1 procedure code in 2024, all of them office visits, for 30 Medicare patients. Medicare paid $3,903 for them. Every service was in an office.

CMS counts 30 Medicare patients who saw Divya Venkat in 2024. The largest group is 65 to 74, with 17 patients. 60% of them have high blood pressure, and 60% have high cholesterol. Their average risk score is 1.68, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Divya Venkat's median patient age at 35, with 66% women.

In 2024, Divya Venkat wrote 890 Medicare Part D claims for 81 patients. 83% of them were for generic drugs. CMS names the drug for 506 of them, across 26 drugs with 11 or more claims each, at $33,948 in total drug cost. In 2023, CMS named 267 claims across 14 drugs.

Divya Venkat accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 17 papers to Divya Venkat, published from 2015 to 2025. 2023 was the busiest year, with 4. The most frequent topics are COVID-19, Pandemics and SARS-CoV-2. Divya Venkat has published most often in ATS Sch. Divya Venkat's most frequent co-authors are Nikos Demetrios Pappan, Luis C. Afonso, MD and M Safwan Badr, MD.

CMS Open Payments shows 1 general payment to Divya Venkat from 1 drug or device company in 2024. Food and beverage make up the largest share, 100% of the total. Hologic Inc paid the most, $29.